8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol

C112H101N17O9 — CID 157364284

IUPAC8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol
SMILESCC(C)c1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cc1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cn1ccnc1Cc1nc2c(Cc3ccccc3)nc(-c3ccccc3)cn2c1O.Oc1ccc(Cc2nc3c(C4CC4)nc(-c4ccccc4)cn3c2O)cc1.Oc1ccc(Cc2nc3c(C4CCCC4)nc(-c4ccccc4)cn3c2O)cc1
InChIInChI=1S/C24H21N5O.C24H23N3O2.C22H19N3O2.C22H21N3O2.C20H17N3O2/c1-28-13-12-25-22(28)15-20-24(30)29-16-21(18-10-6-3-7-11-18)26-19(23(29)27-20)14-17-8-4-2-5-9-17;28-19-12-10-16(11-13-19)14-20-24(29)27-15-21(17-6-2-1-3-7-17)25-22(23(27)26-20)18-8-4-5-9-18;26-17-10-6-14(7-11-17)12-18-22(27)25-13-19(15-4-2-1-3-5-15)23-20(16-8-9-16)21(25)24-18;1-14(2)20-21-24-18(12-15-8-10-17(26)11-9-15)22(27)25(21)13-19(23-20)16-6-4-3-5-7-16;1-13-19-22-17(11-14-7-9-16(24)10-8-14)20(25)23(19)12-18(21-13)15-5-3-2-4-6-15/h2-13,16,30H,14-15H2,1H3;1-3,6-7,10-13,15,18,28-29H,4-5,8-9,14H2;1-7,10-11,13,16,26-27H,8-9,12H2;3-11,13-14,26-27H,12H2,1-2H3;2-10,12,24-25H,11H2,1H3
InChIKeyLOBCLZSPMUHYCK-UHFFFAOYSA-N
MW1829.15 g/mol
LogP21.58
Rot. Bonds20

About 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol

8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol (PubChem CID 157364284) has the molecular formula C112H101N17O9 and a molecular weight of 1829.15 g/mol. Its IUPAC name is 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol.

Molecular Properties

Compound Name8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol
PubChem CID157364284
Molecular FormulaC112H101N17O9
Molecular Weight1829.15 g/mol
Exact Mass1827.80
IUPAC Name8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol
SMILESCC(C)c1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cc1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cn1ccnc1Cc1nc2c(Cc3ccccc3)nc(-c3ccccc3)cn2c1O.Oc1ccc(Cc2nc3c(C4CC4)nc(-c4ccccc4)cn3c2O)cc1.Oc1ccc(Cc2nc3c(C4CCCC4)nc(-c4ccccc4)cn3c2O)cc1
InChIInChI=1S/C24H21N5O.C24H23N3O2.C22H19N3O2.C22H21N3O2.C20H17N3O2/c1-28-13-12-25-22(28)15-20-24(30)29-16-21(18-10-6-3-7-11-18)26-19(23(29)27-20)14-17-8-4-2-5-9-17;28-19-12-10-16(11-13-19)14-20-24(29)27-15-21(17-6-2-1-3-7-17)25-22(23(27)26-20)18-8-4-5-9-18;26-17-10-6-14(7-11-17)12-18-22(27)25-13-19(15-4-2-1-3-5-15)23-20(16-8-9-16)21(25)24-18;1-14(2)20-21-24-18(12-15-8-10-17(26)11-9-15)22(27)25(21)13-19(23-20)16-6-4-3-5-7-16;1-13-19-22-17(11-14-7-9-16(24)10-8-14)20(25)23(19)12-18(21-13)15-5-3-2-4-6-15/h2-13,16,30H,14-15H2,1H3;1-3,6-7,10-13,15,18,28-29H,4-5,8-9,14H2;1-7,10-11,13,16,26-27H,8-9,12H2;3-11,13-14,26-27H,12H2,1-2H3;2-10,12,24-25H,11H2,1H3
InChIKeyLOBCLZSPMUHYCK-UHFFFAOYSA-N
XLogP21.58
TPSA350.84 Ų
H-Bond Donors9
H-Bond Acceptors26
Rotatable Bonds20
Heavy Atoms138
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001829.15
LogP ≤ 521.58
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1026

Analyze 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol?
The IUPAC name of 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol (CID 157364284) is 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol.
What is the SMILES notation for 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol?
The canonical SMILES for 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol is CC(C)c1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cc1nc(-c2ccccc2)cn2c(O)c(Cc3ccc(O)cc3)nc12.Cn1ccnc1Cc1nc2c(Cc3ccccc3)nc(-c3ccccc3)cn2c1O.Oc1ccc(Cc2nc3c(C4CC4)nc(-c4ccccc4)cn3c2O)cc1.Oc1ccc(Cc2nc3c(C4CCCC4)nc(-c4ccccc4)cn3c2O)cc1.
What is the InChIKey of 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol?
The InChIKey is LOBCLZSPMUHYCK-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H21N5O.C24H23N3O2.C22H19N3O2.C22H21N3O2.C20H17N3O2/c1-28-13-12-25-22(28)15-20-24(30)29-16-21(18-10-6-3-7-11-18)26-19(23(29)27-20)14-17-8-4-2-5-9-17;28-19-12-10-16(11-13-19)14-20-24(29)27-15-21(17-6-2-1-3-7-17)25-22(23(27)26-20)18-8-4-5-9-18;26-17-10-6-14(7-11-17)12-18-22(27)25-13-19(15-4-2-1-3-5-15)23-20(16-8-9-16)21(25)24-18;1-14(2)20-21-24-18(12-15-8-10-17(26)11-9-15)22(27)25(21)13-19(23-20)16-6-4-3-5-7-16;1-13-19-22-17(11-14-7-9-16(24)10-8-14)20(25)23(19)12-18(21-13)15-5-3-2-4-6-15/h2-13,16,30H,14-15H2,1H3;1-3,6-7,10-13,15,18,28-29H,4-5,8-9,14H2;1-7,10-11,13,16,26-27H,8-9,12H2;3-11,13-14,26-27H,12H2,1-2H3;2-10,12,24-25H,11H2,1H3.
What are the key properties of 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol?
8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol has a molecular weight of 1829.15 g/mol, XLogP of 21.58, 20 rotatable bonds, 9 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 8-benzyl-2-[(1-methylimidazol-2-yl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopentyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;8-cyclopropyl-2-[(4-hydroxyphenyl)methyl]-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-8-methyl-6-phenylimidazo[1,2-a]pyrazin-3-ol;2-[(4-hydroxyphenyl)methyl]-6-phenyl-8-propan-2-ylimidazo[1,2-a]pyrazin-3-ol is sourced from PubChem (CID 157364284), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).